Open Access Open Access  Restricted Access Subscription or Fee Access

Speech, Swallowing, and Hearing Characteristics in a Patient with Rhino-Orbital-Cerebral Mucormycosis Post COVID-19 Infection: A Case Study

Girish K.S., Pavan K., Apoorva K.S., Vaishnavi Kulkarni, Spoorthi H.S.


Mucormycosis is the third invasive mycosis caused by a growing number of members of the Mucorales; but recently, Rhino-Orbital-Cerebral Mucormycosis has been frequently reported in individuals with COVID-19. The affected areas must be surgically removed to inhibit the spread of illness. Due to the surgical removal of infected areas, individuals with Rhino-Orbital-Cerebral Mucormycosis may develop speech and swallowing issues. Along with speech and swallowing issues, hearing loss was also reported in a few individuals with Rhino-Orbital-Cerebral Mucormycosis following a COVID-19 infection. An adult with a history of Rhino-Orbital-Cerebral Mucormycosis post-COVID-19 infection was evaluated in the Department of Audiology and Speech-Language Pathology, JSS Institute of Speech and Hearing, Dharwad, Karnataka, India. Speech evaluation results revealed speech sound disorder with oral dysphagia and audiological evaluation results revealed mild hearing loss in the right ear and moderately severe to severe hearing loss in the left ear.


Mucormycosis, black fungus, maxillary mucormycosis, speech impairment, hearing impairment, swallowing difficulty, dysphagia, speech sound disorder, voice

Full Text:



Sugar AM. Mucormycosis. Clin Infect Dis. 1992; 14(Suppl 1): S126–S129. doi: 10.1093/clinids/14. supplement_1.s126. PMID: 1562684.

Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54(Suppl 1): S23–S34. doi: 10.1093/cid/cir866. PMID: 22247442.

Bouza E, Munoz P, Guinea J. Mucormycosis: an emerging disease? Clinical Microbiology and Infection. 2006; 12: 7–23p.

Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021; 15(4): 102–146p. doi: 10.1016/j.dsx.2021.05.019.

Hussain S, Riad A, Singh A, Klugarová J, Antony B, Banna H, Klugar M. Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis. Journal of Fungi. 2021; 7(11): 985p.

Elbossaty WF. The Black Fungus is One of the Bad Consequences of COVID-19. Clin Onco. 2021; 5(2): 1–4p.

Dutta S. India reported over 45,000 black fungus cases so far, says Mandaviya in RS. Hindustan Times [Internet]; 2021 July 20. Available from:

Kumar A. Mucormycosis in COVID-19 recovered patients. J Med Virol. 2022; 94(4): 1272–1273p. doi: 10.1002/jmv.27522. Epub 2021 Dec 18. PMID: 34905224.

Dubey S, Mukherjee D, Sarkar P, Mukhopadhyaya P, Barman D, Bandopadhyaya M, Pandit A, Sengupta A, Das S, Ghosh S, Adhikari S, et al. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: An Observational Study from Eastern India, with Special Emphasis on Neurological Spectrum. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2021; 15(5): 102267.

Sekaran A, Patil N, Sabhapandit S, Sistla SK, Reddy DN. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic. IJID Reg. 2022; 2: 99–106p. doi: 10.1016/j.ijregi.2021.12.009.

Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis: an update. Journal of Infection and Public Health. 2012; 5(2): 116–126p. doi: 10.1016/j.jiph.2012.01.003.

Spriestersbach DC. Assessing nasal quality in cleft palate speech of children. J Speech Hear Disord. 1955; 20(3): 266–270p. doi: 10.1044/jshd.2003.

Nagarajan R, Savitha VH, Subramaniyan B. Communication disorders in individuals with cleft lip and palate: An overview. Indian Journal of Plastic Surgery. 2009; 42(S01): S137–S143.

Naunheim MR, Zhou AS, Puka E, Franco Jr RA, Carroll TL, Teng SE, Mallur PS, Song PC. Laryngeal complications of COVID‐19. Laryngoscope Investigative Otolaryngology. 2020; 5(6): 1117–1124p. 15.Hirschberg J. [Functional consequences of cleft palate and its management]. OrvosiHetilap. 2001; 142(24): 1259–1263p. PMID: 11478159.

Swain SK, Pani SR. Incidence of hearing loss in COVID-19 patients: A COVID hospital-based study in the eastern part of India. Int J Curr Res Rev. 2021; 13: 103–107p.

Jati M, Koutsu R, Nagarkar NM. Rhino-Cerebral Mucormycosis with Otologic Involvement. Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2): 3517–3520p. Available from:



  • There are currently no refbacks.

Copyright (c) 2023 Research & Reviews: Journal of Medicine

This Journal archive has been shifted to